Unlabelled: We evaluated the incidence, severity, and predisposing risk factors for hypoglycemic episodes in subjects with type 2 diabetes.
Methods: We conducted a prospective observational study of Southwest veterans with stable, insulin-treated type 2 diabetes who were randomly selected from pharmacy databases. Electronically recorded self-monitored blood glucose (SMBG) results were collected during 12 months of routine monitoring. We defined hypoglycemia as an SMBG reading < or =60 mg/dl. Subjects graded the severity of each hypoglycemic episode: 0=asymptomatic, 1=mild/moderate symptoms, 2=severe, with mental impairment or need for assistance. Subjects also reported any predisposing factors for each hypoglycemic episode.
Results: We enrolled 344 subjects, mean (S.D.) age of 65.5 (9.7) years, 96.5% were men, and 35.2% were minorities. During an average follow-up of 41.2 (8.6) weeks, 176 subjects (51.2%) documented at least one hypoglycemic reading for a total of 1662 episodes. These subjects had a median of six (interquartile range 2-14.9) hypoglycemic episodes. The mean hypoglycemic blood glucose reading was 49.7 (7.5) mg/dl and the mean symptom score was 0.84 (0.45). Nearly 80% of episodes were symptomatic, 3.4% were severe. Subjects identified a cause for 45.2% of episodes: 53.3% of these were attributed to missing a meal, 23.8% to exercise, and 1.6% followed a medication increase.
Conclusions: A high proportion of stable, insulin-treated subjects developed hypoglycemic episodes, but severe hypoglycemia occurred infrequently. Medication increases were rarely identified as causing hypoglycemic episodes. Efforts to achieve tight glycemic control should recognize that patient behaviors commonly cause hypoglycemia.
Download full-text PDF |
Source |
---|---|
http://dx.doi.org/10.1016/j.jdiacomp.2004.02.001 | DOI Listing |
Alzheimers Dement
December 2024
Rush University Medical Center, Chicago, IL, USA.
Background: Abnormal brain insulin signaling has been associated with Alzheimer's disease pathology and a faster rate of late-life cognitive decline. However, the underlying mechanisms remain unclear. In this study, we examined whether AD-related cortical proteins identified using targeted-proteomics play a role in the association of brain insulin signaling and cognitive decline.
View Article and Find Full Text PDFCureus
November 2024
Medicine, SGT Medical College, Hospital and Research Institute, Gurugram, IND.
Objective: This research aimed to assess the prevalence, presentation, and risk factors associated with hypoglycemia in non-critically ill vs. critically ill inpatients at a tertiary care hospital in North India, focusing on identifying differences in clinical parameters and outcomes between these two patient populations over six months.
Methodology: This six-month prospective study, conducted at a tertiary care hospital in North India, evaluated the frequency, presentation, and prevention of hypoglycemia in 200 hospitalized patients, evenly divided between non-critically ill and critically ill groups.
Cureus
November 2024
Department of Internal Medicine, B. J. Medical College and Civil Hospital, Ahmedabad, IND.
Hypoglycemia in non-diabetic individuals is a rare but critical condition that often signals an underlying pathology. Insulinoma, a rare neuroendocrine tumor of the pancreas, is a key differential diagnosis. As the most common functional pancreatic neuroendocrine tumors, insulinomas originate from pancreatic islet cells and are predominantly benign.
View Article and Find Full Text PDFSci Rep
December 2024
Computer Science Department, Indiana University, Bloomington, IN, USA.
Pediatric diabetes I is an endemic and an especially difficult disease; indeed, at this point, there does not exist a cure, but only careful management that relies on anticipating hypoglycemia. The changing physiology of children producing unique blood glucose signatures, coupled with inconsistent activities, e.g.
View Article and Find Full Text PDFJ Diabetes Sci Technol
December 2024
Department of Family and Community Medicine, University of California San Francisco, San Francisco, CA, USA.
Background: Recent advances in diabetes care and technology, such as real-time continuous glucose monitoring, can help people live more freely, with more flexibility and fewer constraints, thereby enhancing quality of life (QOL). To date, there has been no validated means for measuring this key psychological dimension. We developed the Diabetes Constraints Scale (DCS) to assess perceived constraints pertaining to diabetes self-management.
View Article and Find Full Text PDFEnter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!